SRSD384
/ Sirius Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 30, 2026
A Study of SRSD384 in Overweight or Obese Participants
(clinicaltrials.gov)
- P1/2 | N=78 | Not yet recruiting | Sponsor: Sirius Therapeutics Co., Ltd.
New P1/2 trial • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1